Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
3SBio Inc (1530 HK)
Watchlist
Contact IR
131
Analysis
Health Care
•
China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Bio-Thera Solutions Ltd
•
05 Jan 2021 01:51
Pre-IPO Bio-Thera Solutions - Insights on Pipeline and the Competitive Landscape
This article summarized the insights on major products of Bio-Thera Solutions in the pipeline and related competitive landscape with other key...
Xinyao (Criss) Wang
Follow
430 Views
Share
bullish
•
Alibaba Health Information Tec
•
18 Dec 2020 12:56
China Healthcare: Macro Themes
This Insight summarizes the takeaways from a recent China healthcare industry conference. There is much talk of pressures on the industry, but...
Kemp Dolliver, CFA
546 Views
Share
bullish
•
HBM Holdings Limited
•
02 Dec 2020 01:36
Harbour Biomed IPO: Positive Thoughts in Brief
This Insight includes a brief analysis of Harbour Biomed and its proposed listing on the HKEX. We like the deal at the price range offered.
Kemp Dolliver, CFA
414 Views
Share
bullish
•
Simcere Pharmaceutical Group
•
14 Oct 2020 08:08
Simcere Pharmaceutical IPO: Valuation Insights
We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range
Arun George
Follow
524 Views
Share
bearish
•
Quantitative Analysis
•
29 Jun 2020 08:29
Asia Short Interest Weekly - Big Jump in Japan Shorts
The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...
Brian Freitas
Follow
374 Views
Share
First
Previous
14
15
16
17
18
19
20
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.3
x